Clinical Trial Update: Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ethosomal and liposomal formulations of anthralin for psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Anthralin (formulations: ethosomal and liposomal) (anthralin)

Snippet

Sponsor: Assiut University | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED